We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
23 Sep 2021 - 25 Sep 2021

Elevated PlGF Levels Found with Acute Fatty Liver of Pregnancy

By LabMedica International staff writers
Posted on 22 Jul 2021
Print article
Image: The ROCHE Cobas 6000 Chemistry Analyzer (Photo courtesy of Roche Diagnostics)
Image: The ROCHE Cobas 6000 Chemistry Analyzer (Photo courtesy of Roche Diagnostics)
Acute fatty liver of pregnancy (AFLP) is a severe liver disorder unique to pregnancy, typically occurring after 30 weeks’ gestation. Although uncommon, with an estimated global incidence of 1 in 7,000 to 15,000 pregnancies, AFLP is a life-threatening disease for both mother and child.

During preeclampsia, poor placentation triggers the excessive release of the soluble vascular endothelial growth factor receptors (VEGFR); also known as soluble Fms-like tyrosine kinase-1 (sFlt-1), which binds its free circulating ligands VEGF and placental growth factor (PlGF). The ensuing angiogenic imbalance is thought to contribute significantly to the clinical manifestations of this disorder.

Physicians at the Erasmus MC University Hospital (Rotterdam, the Netherlands) and their colleagues utilized human serum samples from a database of women with singleton pregnancies who had a clinical diagnosis of AFLP between 2005 and 2020. The team compared matched women with AFLP to 12 gestational age (GA) matched women with either no preeclampsia, confirmed preeclampsia, or HELLP syndrome, given that the values of sFlt-1, free, and total PlGF alter with advancing gestation.

Measurement of sFlt-1, Free PlGF, and Total PlGF was carried out. For the thermal dissociation of all sFlt-1-PlGF complexes, serum samples were placed in a heating block at 70 °C for 10 minutes. Measurements of sFlt-1 and PlGF before and after heating were performed using the automated Elecsys immunoassay from Roche Diagnostics (Cobas 6000, e-module; Rotterdam, the Netherlands).

The scientist found that median levels of free PlGF were significantly lower in 13 women with preeclampsia (117pg/mL) or in 12 women with hemolysis elevated liver enzymes and low platelet count syndrome (59 pg/mL) compared with 11 women without preeclampsia (349 pg/mL). In contrast, median total PlGF did not differ between women with no preeclampsia, preeclampsia, and hemolysis elevated liver enzymes and low platelet count syndrome (354 pg/mL versus 435 pg/mL versus 344 pg/mL) respectively, whereas it was markedly elevated in AFLP compared with all groups (2,054 pg/mL). Furthermore, in AFLP, both sFlt-1 and total PlGF declined rapidly post-delivery, with significantly higher in 12 pre-delivery total PlGF (median, 2,054 pg/mL) than 14 postpartum levels (median, 163 pg/mL), suggesting that in AFLP, PlGF is largely placenta-derived.

The authors concluded that their findings indicated that like sFlt-1, PlGF production is significantly upregulated in AFLP, mainly originating from the placenta. Importantly, total PlGF can now be easily calculated from already available free PlGF and sFlt-1 levels, allowing subsequent evaluation of other groups in whom PlGF is altered. The study was published on June 28, 2021in the journal Hypertension.

Related Links:
Erasmus MC University Hospital
Roche Diagnostics


Gold Supplier
SARS-CoV-2 Antibody Test
SARS-CoV-2 UTAB FS
New
Silver Supplier
COVID-19 IgG-IgM Rapid Test
COVID-19 IgG-IgM Rapid Test
New
Silver Supplier
Cartridge Incubator
WS-i60 Cartridge Incubator
New
Gold Supplier
Liquid Handling Workstation
AdvanSure E3 SYSTEM

Print article

Channels

Immunology

view channel
Illustration

First-Of-Its Kind Blood Test to Distinguish between Bacterial and Viral Infections Using Body’s Immune Response Granted FDA Clearance

A first-of-its kind test that decodes the immune response to accurately distinguish between bacterial or viral infections within minutes has been granted clearance by the US Food and Drug Administration (FDA).... Read more

Pathology

view channel
Image: The CellSearch Circulating Tumor Cell Kit is intended for the enumeration of circulating tumor cells of epithelial origin (CD45-, EpCAM+, and cytokeratins 8, 18+, and/or 19+ and PD-L1) in whole blood (Photo courtesy of CellSearch/Menarini Silicon Biosystems)

PD-L1 Expression in Circulating Tumor Cells Investigated for NSCLC

In non-small cell lung cancer (NSCLC), analysis of programmed cell death ligand 1 (PD-L1) expression in circulating tumor cells (CTCs) is a potential alternative to overcome the problems linked to the... Read more

Industry

view channel
Illustration

Thermo Fisher Launches World’s First Fully Integrated Digital PCR (dPCR) System

Thermo Fisher Scientific Inc. (Waltham, MA, USA) has launched the world’s first fully integrated digital PCR (dPCR) system designed to provide highly accurate and consistent results within 90 minutes.... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.